Literature DB >> 20936413

Diffusion weighted imaging in prostate cancer.

Cher Heng Tan1, Jihong Wang, Vikas Kundra.   

Abstract

Diffusion-weighted imaging has generated substantial interest in the hope that it can be developed into a robust technique to improve the accuracy of MRI for the evaluation of prostate cancer. This technique has the advantages of short acquisition times, no need for intravenous administration of contrast medium, and the ability to study diffusion of water molecules that indirectly reflects tissue cellularity. In this article, we review the existing literature on the utility of DWI in tumour detection, localisation, treatment response, limitations of the technique, how it compares with other imaging techniques, technical considerations and future directions.

Entities:  

Mesh:

Year:  2010        PMID: 20936413     DOI: 10.1007/s00330-010-1960-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  70 in total

1.  High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features.

Authors:  M C DeLano; T G Cooper; J E Siebert; M J Potchen; K Kuppusamy
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

2.  Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.

Authors:  Jean Pouliot; Yongbok Kim; Etienne Lessard; I-Chow Hsu; Daniel B Vigneron; John Kurhanewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

3.  Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients.

Authors:  S F Riches; K Hawtin; E M Charles-Edwards; N M de Souza
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

Review 4.  Diffusion-weighted magnetic resonance imaging and its application to cancer.

Authors:  Elizabeth M Charles-Edwards; Nandita M deSouza
Journal:  Cancer Imaging       Date:  2006-09-13       Impact factor: 3.909

5.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.

Authors:  Bashar Issa
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

6.  Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy.

Authors:  Byung Kwan Park; Hyun Moo Lee; Chan Kyo Kim; Han Yong Choi; Jong Wook Park
Journal:  Invest Radiol       Date:  2008-11       Impact factor: 6.016

7.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.

Authors:  Tsutomu Tamada; Teruki Sone; Yoshimasa Jo; Akira Yamamoto; Takenori Yamashita; Naoto Egashira; Shigeki Imai; Masao Fukunaga
Journal:  Radiology       Date:  2008-06-06       Impact factor: 11.105

8.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.

Authors:  Deanna L Langer; Theodorus H van der Kwast; Andrew J Evans; Laibao Sun; Martin J Yaffe; John Trachtenberg; Masoom A Haider
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

9.  Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.

Authors:  V A Morgan; S Kyriazi; S E Ashley; N M DeSouza
Journal:  Acta Radiol       Date:  2007-07       Impact factor: 1.990

10.  Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.

Authors:  N M deSouza; S F Riches; N J Vanas; V A Morgan; S A Ashley; C Fisher; G S Payne; C Parker
Journal:  Clin Radiol       Date:  2008-04-18       Impact factor: 2.350

View more
  27 in total

1.  Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer.

Authors:  Hyeyeol Bae; Soichiro Yoshida; Yoh Matsuoka; Hiroshi Nakajima; Eisaku Ito; Hiroshi Tanaka; Miyako Oya; Takayuki Nakayama; Hideki Takeshita; Toshiki Kijima; Junichiro Ishioka; Noboru Numao; Fumitaka Koga; Kazutaka Saito; Takumi Akashi; Yasuhisa Fujii; Kazunori Kihara
Journal:  Int Urol Nephrol       Date:  2014-03       Impact factor: 2.370

2.  Exponential apparent diffusion coefficient in evaluating prostate cancer at 3 T: preliminary experience.

Authors:  Sung Y Park; Chan K Kim; Jung J Park; Byung K Park
Journal:  Br J Radiol       Date:  2015-12-10       Impact factor: 3.039

3.  Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging.

Authors:  Thomas de Perrot; Olivier Rager; Max Scheffler; Martin Lord; Marc Pusztaszeri; Christophe Iselin; Osman Ratib; Jean-Paul Vallee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

4.  Feasibility study of CT perfusion imaging for prostate carcinoma.

Authors:  Nesat Cullu; Mecit Kantarci; Hayri Ogul; Senol Adanur; Aylin Okur; Erdem Koc; Berhan Pirimoglu; Leyla Karaca; Yesim Kizrak; Ozkan Polat
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

Review 5.  Biparametric MRI of the prostate.

Authors:  Michele Scialpi; Alfredo D'Andrea; Eugenio Martorana; Corrado Maria Malaspina; Maria Cristina Aisa; Maria Napoletano; Emanuele Orlandi; Valeria Rondoni; Pietro Scialpi; Diamante Pacchiarini; Diego Palladino; Michele Dragone; Giancarlo Di Renzo; Annalisa Simeone; Giampaolo Bianchi; Luca Brunese
Journal:  Turk J Urol       Date:  2017-12-01

Review 6.  Locally advanced prostate cancer imaging findings and implications for treatment from the surgical perspective.

Authors:  Sherif B Elsherif; Vishnupriya Kuchana; Rizwan Aslam; Ashish Kamat; Priya R Bhosale; A R Klekers
Journal:  Abdom Radiol (NY)       Date:  2020-03

7.  Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?

Authors:  L Van den Bergh; S Isebaert; M Koole; R Oyen; S Joniau; E Lerut; C M Deroose; F De Keyzer; H Van Poppel; K Haustermans
Journal:  Strahlenther Onkol       Date:  2013-09       Impact factor: 3.621

8.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

9.  The "PROCAINA (PROstate CAncer INdication Attitudes) Project" (Part II)--a survey among Italian radiation oncologists on radical radiotherapy in prostate cancer.

Authors:  Berardino De Bari; Filippo Alongi; Pierfrancesco Franco; Patrizia Ciammella; Tarik Chekrine; Lorenzo Livi; Barbara A Jereczek-Fossa; Andrea Riccardo Filippi
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

Review 10.  Prostate focused ultrasound focal therapy--imaging for the future.

Authors:  Olivier Rouvière; Albert Gelet; Sébastien Crouzet; Jean-Yves Chapelon
Journal:  Nat Rev Clin Oncol       Date:  2012-08-21       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.